Ruff Shamim - Insider Non-Derivative Transactions at REATA PHARMACEUTICALS INC (RETA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 26, 2023, Ruff Shamim's relationship to REATA PHARMACEUTICALS INC (RETA) is Director, and currently has 0 shares of Class A common stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RETA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Ruff Shamim - Insider Non-Derivative Transactions of RETA Class A common stock

Ruff Shamim - Insider Non-Derivative Transactions at RETA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 27, 2023	Disposition -- (Class A common stock)	7359	0	0
Jul 29, 2023	Sell -- (Class A common stock)	8235	164.53	7359
Jul 29, 2023	M -- (Class A common stock)	1250	92.2	8609
Jul 29, 2023	M -- (Class A common stock)	6666	92.2	15275
Jul 29, 2023	M -- (Class A common stock)	319	92.2	15594
Jun 8, 2023	Acquisition -- (Class A common stock)	454	93.61	5677
Jun 8, 2023	Acquisition -- (Class A common stock)	1682	93.61	7359
Mar 11, 2023	Sell -- (Class A common stock)	5740	83.73	5223
Mar 11, 2023	M -- (Class A common stock)	199	27.32	5422
Mar 11, 2023	M -- (Class A common stock)	1326	34.76	6748
Mar 11, 2023	M -- (Class A common stock)	4215	34.76	10963